Inventor

ROSENBERG STEVEN A

US142 patents

⚠️ This page may combine multiple inventors who share the name “ROSENBERG STEVEN A”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

ROSENBERG STEVEN A

US HEALTH

Melanoma antigens and their use in diagnostic and therapeutic methods

Melanoma antigens and their use in diagnostic and therapeutic methods

Melanoma antigens and their use in diagnostic and therapeutic methods

Tumor infiltrating lymphocytes as a treatment modality for human cancer

Adoptive immunotherapy as a treatment modality in humans

Adoptive cell therapy with young T cells

Adoptive cell therapy with young T cells

Alternative open reading frame DNA of a normal gene and a novel human cancer antigen encoded therein

Methods of producing enriched populations of tumor reactive T cells from peripheral blood

Immunotherapy with in vitro-selected antigen-specific lymphocytes after non-myeloablative lymphodepleting chemotherapy

T-cell receptors and their use in therapeutic and diagnostic methods

Melanoma antigens and their use in diagnostic and therapeutic methods

Melanoma antigens and their use in diagnostic and therapeutic methods

Melanoma antigens and their use in diagnostic and therapeutic methods

Antibodies specific for TRP-2 a human tumor antigen recognized by cytotoxic T lymphocytes

Identification of TRP-2 as a human tumor antigen recognized by cytotoxic T lymphocytes

Methods and compositions for transforming dendritic cells and activating T cells

Anti-human papillomavirus 16 E7 T cell receptors

Immunogenic chimeras comprising nucleic acid sequences encoding endoplasmic reticulum signal sequence peptides and at least one other peptide, and their uses in vaccines and disease treatments

Methods of isolating T cells and T cell receptors having antigenic specificity for a cancer-specific mutation from peripheral blood

Anti-epidermal growth factor receptor variant III chimeric antigen receptors and use of same for the treatment of cancer

Anti-mesothelin chimeric antigen receptors

Compositions comprising T cell receptors and methods of use thereof

Anti-human papillomavirus 16 E6 T cell receptors

MHC class II restricted T cell epitopes from the cancer antigen, NY ESO-1

Identification of TRP-2 as a human tumor antigen recognized by cytotoxic T lymphocytes

P15 and tyrosinase melanoma antigens and their use in diagnostic and therapeutic methods

Anti-vascular endothelial growth factor receptor-2 chimeric antigen receptors and use of same for the treatment of cancer

Anti-vascular endothelial growth factor receptor-2 chimeric antigen receptors and use of same for the treatment of cancer

Murine anti-NY-ESO-1 T cell receptors

Adoptive immunotherapy with enhanced T lymphocyte survival

MORGAN RICHARD A

Anti-epidermal growth factor receptor variant III chimeric antigen receptors and use of same for the treatment of cancer

Anti-SSX-2 T cell receptors and related materials and methods of use

Inducible interleukin-12

UNIV MINNESOTA

Intracellular genomic transplant and methods of therapy

Modified cells and methods of therapy

ROBBINS PAUL F

Modified T cell receptors and related materials and methods

Modified T cell receptors and related materials and methods

KITE PHARMA INC

Methods of conditioning patients for T cell therapy

Methods of conditioning patients for T cell therapy

ROSENBERG STEVEN A

Anti-vascular endothelial growth factor receptor-2 chimeric antigen receptors and use of same for the treatment of cancer

T cell receptors and related materials and methods of use

US ARMY

Gene therapy

ESHHAR ZELIG

Chimeric receptor genes and cells transformed therewith

THERION BIOLOG CORP

Methods of in vivo gene delivery

DUDLEY MARK E

Immunotherapy with in vitro-selected antigen-specific lymphocytes after nonmyeloablative lymphodepleting chemotherapy

US GOV HEALTH & HUMAN SERV

Immunogenic chimeras comprising nucleic acid sequences encoding endoplasmic reticulum signal sequence peptides and at least one other peptide, and their uses in vaccines and disease treatments

UNIV JOHNS HOPKINS

Melanoma cell lines expressing shared immunodominant melanoma antigens and methods of using same

SIKA TECHNOLOGY AG

Polyurethane adhesive for windshield applications

RESTIFO NICHOLAS P

GP100-specific T cell receptors and related materials and methods of use